European Society for Medical Oncology (ESMO) 2019 Congress - X4 Pharmaceuticals

European Society for Medical Oncology (ESMO) 2019 Congress

European Society for Medical Oncology (ESMO) 2019 Congress

September 2019

Safety and Efficacy of the Oral CXCR4 Inhibitor X4P-001 + Axitinib in Advanced Renal Cell Carcinoma Patients: An Analysis of Subgroup Responses by Prior Treatment

© Copyright 2025 X4 Pharmaceuticals. All Rights Reserved. Terms of Use | Privacy | Compliance and Ethics